Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels.

Argel, M I; Vittone, L; Grassi, A O; Chiappe, L E; Chiappe, G E; Cingolani, H E

Argel, M I; Vittone, L; Grassi, A O; Chiappe, L E; Chiappe, G E; Cingolani, H E.

J Mol Cell Cardiol ; 12(10): 939-54, 1980 Oct.

Article in En | MEDLINE | ID: mdl-6257913

Subject(s)

Myocardial Contraction/drug effects; Myocardium/metabolism; Nucleotides, Cyclic/metabolism; Phosphodiesterase Inhibitors/pharmacology; Protein Kinases/metabolism; Animals; Cyclic AMP/metabolism; Cyclic AMP/pharmacology; Cyclic GMP/metabolism; Papaverine/pharmacology; Pentoxifylline/pharmacology; Rats; Theophylline/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Protein Kinases / Myocardial Contraction / Myocardium / Nucleotides, Cyclic Limits: Animals Language: En Journal: J Mol Cell Cardiol Year: 1980 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links